SCHEMBL8886569

SCHEMBL8886569

COC(=O)c1cc(CCO)ccc1NC(C)=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP4A11 Q02928 5/20 0.50
CYP4F2 P78329 4/20 0.50
KDM4E B2RXH2 4/20 0.44
ALDH1A1 P00352 3/20 0.44
HSD17B10 Q99714 3/20 0.44
MAPT P10636 2/20 0.44
HPGD P15428 2/20 0.44
GAA P10253 1/20 0.44
ALOX15 P16050 1/20 0.44
TSHR P16473 1/20 0.44
LMNA P02545 2/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
KMT2A Q03164 2/20 0.42
CYP2C19 P33261 2/20 0.42
MEN1 O00255 1/20 0.42
CYP1A2 P05177 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
CYP2C9 P11712 1/20 0.41
HTT P42858 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26046942 0.86 RAB9A (0.49) KDM4EALDH1A1HSD17B10MAPTHPGD
SCHEMBL8887409 0.85 KDM4E (0.58) KDM4EALDH1A1HSD17B10CYP2C19
SCHEMBL8888175 0.82 ALDH1A1 (0.44) KDM4EALDH1A1HSD17B10MAPTHPGD
SCHEMBL23635271 0.81 MAPT (0.47) KDM4EALDH1A1HSD17B10MAPTHPGD
SCHEMBL10610210 0.81 CYP4A11 (0.58) CYP4A11CYP4F2KDM4EALDH1A1HSD17B10
SCHEMBL29112786 0.78 CA12 (0.59) CYP4A11CYP4F2KDM4EALDH1A1HSD17B10
SCHEMBL23927644 0.78 CYP4A11 (0.55) CYP4A11CYP4F2KDM4EALDH1A1HSD17B10
SCHEMBL1025962 0.78 CA12 (0.62) KDM4EALDH1A1HSD17B10MAPTGAA
SCHEMBL1826678 0.78 MTNR1B (0.52) KDM4EALDH1A1HSD17B10MAPTHPGD
SCHEMBL30394564 0.77 CYP4A11 (0.54) CYP4A11CYP4F2KDM4EALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5602277-A Substituted benzene derivatives useful as neuraminidase inhibitors BIOCRYST PHARMACEUTICALS, INC. (US) 1997-02-11 US disclosed
WO-1996030329-A1 SUBSTITUTED BENZENE DERIVATIVES USEFUL AS NEURAMINIDASE INHIBITORS BIOCRYST PHARMACEUTICALS, INCORPORATED (US) 1996-10-03 WO disclosed